ISDA

Deposition Date 2015-08-31

Release Date 2016-01-13

Last Version Date 2023-09-27

Entry Detail

PDB ID:

5DI1

Keywords:

TRANSFERASE/INHIBITOR

Title:

MAP4K4 in complex with an inhibitor

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Insect cell expression vector pTIE1

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.90 Å

R-Value Free:

0.24

R-Value Work:

0.19

R-Value Observed:

0.20

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Mitogen-activated protein kinase kinase kinase kinase 4
Gene (Uniprot):MAP4K4
Chain IDs:A, B
Chain Length:310
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:O95819 Pfam ID:PF00069

Ligand Molecules

5DF

Primary Citation

Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based Antidiabetic Treatment.

Ammirati, M, Bagley, S.W, Bhattacharya, S.K, Buckbinder, L, Carlo, A.A, Conrad, R, Cortes, C, Dow, R.L, Dowling, M.S, El-Kattan, A, Ford, K, Guimaraes, C.R, Hepworth, D, Jiao, W, LaPerle, J, Liu, S, Londregan, A, Loria, P.M, Mathiowetz, A.M, Munchhof, M, Orr, S.T, Petersen, D.N, Price, D.A, Skoura, A, Smith, A.C, Wang, J.Show

Acs Med.Chem.Lett. 6 1128 1133 (2015)

PMID: 26617966 DOI: 10.1021/acsmedchemlett.5b00215

Abstact

Recent studies in adipose tissue, pancreas, muscle, and macrophages suggest that MAP4K4, a serine/threonine protein kinase may be a viable target for antidiabetic drugs. As part of the evaluation of MAP4K4 as a novel antidiabetic target, a tool compound, 16 (PF-6260933) and a lead 17 possessing excellent kinome selectivity and suitable properties were delivered to establish proof of concept in vivo. The medicinal chemistry effort that led to the discovery of these lead compounds is described herein together with in vivo pharmacokinetic properties and activity in a model of insulin resistance.

Legend

Protein

Chemical

Disease

Primary Citation of related structures